Jeffrey Thompson, PhD

Articles

Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice

February 09, 2022

Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.